Stephen Denzer
Internal Medicine · Kealakekua, HINPI 1992742654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations.
Across 164 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$670
- Lilly USA, LLC$427
- AstraZeneca$381
- Novo Nordisk$324
- Johnson & Johnson$279
- AbbVie$252
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,376100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 26 | $670 |
| Lilly USA, LLC | 19 | $427 |
| AstraZeneca | 20 | $381 |
| Novo Nordisk | 20 | $324 |
| Johnson & Johnson | 20 | $279 |
| AbbVie(2 entities) | 10 | $252 |
| Bayer | 10 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $193 |
| Amgen | 6 | $123 |
| Merck | 5 | $115 |
| Boehringer Ingelheim | 5 | $111 |
| Pfizer | 4 | $73 |
| GSK | 2 | $54 |
| Abbott | 1 | $43 |
| Insmed, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Gilead | 1 | $17 |
How this compares
$3,376 in reported general payments places this provider in the 80th percentile of 655 internal medicine providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Kealakekua
- Scott StromattKamuela$385K
- Keith WooHonolulu$106K
- Ronald PerryHonolulu$102K
- Laurie TomHonolulu$95K
- Yusuke MiyataniHonolulu$80K
- Joshua TanHonolulu$76K
- Jose de LeonHonolulu$52K
- Peter DeeHonolulu$49K
- James LumengHonolulu$45K
- Charles ZerezHonolulu$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.